Skip to main content
OpenTrials
Completed

NCT Number: NCT04658745

Effects of Theta Burst Stimulation on Modulation of Mirror Illusion-induced Rhythm Suppression in Stroke

The study aims to test the hypothesis that rTMS in the form of theta burst stimulation (TBS) over the ipsilateral and contralateral motor cortices can modulate mirror illusion-induced rhythm suppression while observing unilateral arm movement in stroke individuals. The investigators further hypothesize that this intervention will lead to the revision of interhemispheric asymmetry. Finally, this study will also explore the longitudinal relationship between rhythm suppression and motor recovery as indicated by motor excitability in the form of MEP. The results of this study will provide significant new information regarding neurophysiological motor relearning mechanisms which could inform the development and evaluation of innovative treatments for individuals with stroke

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Kenneth FONG

Hong Kong, 000000

About this study

Stroke is the leading cause of physical disability. Facilitating the process of motor relearning would greatly accelerate the rehabilitation of motor functions and elicit positive neuroplasticity of the damaged brain area. Previous research has already explored the feasibility of motor priming techniques embedded in stroke rehabilitation programs using strategies such as non-invasive brain stimulation (NIBS) and mirror therapy (MT). These treatments are usually implemented along with the standardized rehabilitation, sequentially or simultaneously, and have been demonstrated to be more effective than the standardized rehabilitation programs alone.

Mirror neuron, as indicated traditionally by the decrease in the amplitude of Mu rhythm, i.e. a suppression over central electrodes of electroencephalography (EEG), reflects the "seeing" of movement after "perception". Such oscillations are based on neural substrates that are discharged during the observation and execution of a motor act, which is also associated with other human functions, such as imitation, language, etc. The core mirror neuron system (MNS) is thought to be located in the premotor and the primary sensorimotor cortices, indicating that motor learning could be enhanced during action observation and overt movement.

Preliminary research has shown that repetitive Transcranial Magnetic Stimulation (rTMS) can enhance the corticomotor excitability in mirror neurons during both observation of movement (by others) or imagined movement in healthy subjects; in particular, as measured by enhanced motor evoked potentials (MEP). Increases in MEP has also been induced by short-term action observation and mirror visual feedback in stroke survivors. However, it is not yet known if MNS can be activated by TMS in MT following a stroke, and the relationship between mirror neuron activation and clinical improvements in stroke remains unclear.

The investigators have already published preliminary findings in patients with hemiplegic upper extremity, rTMS, and MT. Here, the investigators propose to test the hypothesis that rTMS in the form of theta-burst stimulation (TBS) over the ipsilateral and contralateral motor cortices can modulate mirror illusion-induced rhythm suppression while observing unilateral arm movement in stroke individuals. The investigators further hypothesize that this intervention will lead to the revision of interhemispheric asymmetry. Finally, this study will also explore the longitudinal relationship between rhythm suppression and motor recovery as indicated by motor excitability in the form of MEP. The results of this study will provide significant new information regarding neurophysiological motor relearning mechanisms which could inform the development and evaluation of innovative treatments for individuals with stroke

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • type and location of stroke - ischemic or hemorrhagic, cortical or subcortical, confirmed by medical diagnoses compatible with a unilateral lesion involvement;
  • Acute stroke patients: stroke with onset of neurological condition ≤3 months, recruited from a local hospital; Chronic stroke patients: stroke with onset of neurological condition from 6 months to 3 years, recruited from self-help organization in the community. The randomization will be pre-stratified into 2 - subacute and chronic stages, and recruit from 2 centers - acute hospital and self-help organizations in the community.
  • normal or corrected-to-normal visual acuity better than 20/60 (6/18) in the better eye;
  • right-handed, verified by the Edinburgh Handedness Inventory;
  • mild to moderately impaired hemiplegic upper extremity functions, with functional levels 5-7 as rated by the Functional Test for the Hemiplegic Upper Extremity - Hong Kong version (FTHUE-HK);
  • the ability to understand and follow simple verbal instructions;
  • the ability to participate in a therapy session lasting at least 60 minutes; and
  • consent to participate in the study.

Exclusion criteria

  • prior neurological or psychiatric disorders;
  • severe spasticity (Modified Ashworth Scale >3) over hemiplegic upper extremity;
  • a history of recent Botox injections or acupuncture to the hemiplegic upper extremity within the past three months;
  • use of central nervous system-active medicine;
  • any contraindication to TMS, according to the guideline of the Safety of TMS Consensus group, such as the risk of epilepsy, metal implants, and pregnancy;
  • the presence of unilateral neglect as screened by the Behavioural Inattention Test (CBIT-HK); and
  • participation in another clinical study elsewhere during recruitment. Informed written consent will be obtained from all patients prior to data collection.

Treatment and study plan

Intermittent Theta Burst Stimulation

Device

iTBS (20 trains of ten bursts at eight-second intervals, 600 stimuli, 200-second per session) will be delivered to the ipsilesional hemisphere in stroke patients, by using a butterfly shape coil.

Mirror Therapy

Behavioral

Participants will practice the movements with the non-affected hand and try moving the affected arm at the same time to synchronize with the non-affected hand (illusion on the mirror). The movement practice will involve 5 table-top tasks and the participant will be instructed to perform as many trials as possible in each session with a maximum of 30 trials per task, giving a total of 150 trials per session, lasting for 20 minutes.

Sham Intermittent Theta Burst Stimulation

Device

iTBS (20 trains of ten bursts at eight-second intervals, 600 stimuli, 200-second per session) will be delivered to the ipsilesional hemisphere in stroke patients. However, a sham coil will be used, which is not associated with any stimulation effect on the brain.

Sham Mirror Therapy

Behavioral

In sham mirror therapy, the mirror will be covered. Participants will practice the movements with the non-affected hand and try moving the affected arm at the same time to move the non-affected hand. The participants cannot receive mirror visual feedback of the paretic upper extremity movement during the therapy. Same as mirror therapy, the movement practice will involve 5 table-top tasks and the participant will be instructed to perform as many trials as possible in each session with a maximum of 30 trials per task, giving a total of 150 trials per session, lasting for 20 minutes.

Primary outcomes

  1. Fugl-Meyer assessment (FMA)

    Time frame: Baseline

    A stroke-specific, performance-based impairment index

  2. Fugl-Meyer assessment (FMA)

    Time frame: 1 day

    A stroke-specific, performance-based impairment index

  3. Fugl-Meyer assessment (FMA)

    Time frame: 2 weeks

    A stroke-specific, performance-based impairment index

  4. Fugl-Meyer assessment (FMA)

    Time frame: 1-month after the completion of the intervention

    A stroke-specific, performance-based impairment index

  5. Action Research Arm Test (ARAT)

    Time frame: Baseline (immediately before the first session)

    A measure of upper extremity performance (coordination, dexterity and functioning) in stroke recovery

  6. Action Research Arm Test (ARAT)

    Time frame: 1 day

    A measure of upper extremity performance (coordination, dexterity and functioning) in stroke recovery

  7. Action Research Arm Test (ARAT)

    Time frame: 2 weeks

    A measure of upper extremity performance (coordination, dexterity and functioning) in stroke recovery

  8. Action Research Arm Test (ARAT)

    Time frame: 1-month after the completion of the intervention

    A measure of upper extremity performance (coordination, dexterity and functioning) in stroke recovery

Secondary outcomes

  1. EEG rhythm power

    Time frame: Baseline (immediately before the first session)

    Rhythm power desynchronization/synchronization in response to mirror visual feedback

  2. EEG rhythm power

    Time frame: 1 day

    Rhythm power desynchronization/synchronization in response to mirror visual feedback

  3. EEG rhythm power

    Time frame: 2 weeks

    Rhythm power desynchronization/synchronization in response to mirror visual feedback

  4. EEG rhythm power

    Time frame: 1-month after the completion of the intervention

    Rhythm power desynchronization/synchronization in response to mirror visual feedback

  5. Motor-evoked Potential (MEP)

    Time frame: Baseline (immediately before the first session)

    Electrical potential recorded over a hand muscle, evoked by stimulating the primary motor cortex.

  6. Motor-evoked Potential (MEP)

    Time frame: 1 day

    Electrical potential recorded over a hand muscle, evoked by stimulating the primary motor cortex.

  7. Motor-evoked Potential (MEP)

    Time frame: 2 weeks

    Electrical potential recorded over a hand muscle, evoked by stimulating the primary motor cortex.

  8. Motor-evoked Potential (MEP)

    Time frame: 1-month after the completion of the intervention

    Electrical potential recorded over a hand muscle, evoked by stimulating the primary motor cortex

  9. Cortical silent period

    Time frame: Baseline (immediately before the first session)

    The cortical silent period (cSP) refers to an interruption of voluntary muscle activities during contraction by stimulating the contralateral primary motor cortex.

  10. Cortical silent period

    Time frame: 1 day

    The cortical silent period (cSP) refers to an interruption of voluntary muscle activities during contraction by stimulating the contralateral primary motor cortex.

  11. Cortical silent period

    Time frame: 2 weeks

    The cortical silent period (cSP) refers to an interruption of voluntary muscle activities during contraction by stimulating the contralateral primary motor cortex.

  12. Cortical silent period

    Time frame: 1-month after the completion of the intervention

    The cortical silent period (cSP) refers to an interruption of voluntary muscle activities during contraction by stimulating the contralateral primary motor cortex.

  13. Ipsilateral silent period

    Time frame: Baseline (immediately before the first session)

    Ipsilateral silent period (iSP) is an interruption of ongoing muscle activities caused by stimulating ipsilateral primary motor cortex.

  14. Ipsilateral silent period

    Time frame: 1 day

    Ipsilateral silent period (iSP) is an interruption of ongoing muscle activities caused by stimulating ipsilateral primary motor cortex.

  15. Ipsilateral silent period

    Time frame: 2 weeks

    Ipsilateral silent period (iSP) is an interruption of ongoing muscle activities caused by stimulating ipsilateral primary motor cortex.

  16. Ipsilateral silent period

    Time frame: 1-month after the completion of the intervention

    Ipsilateral silent period (iSP) is an interruption of ongoing muscle activities caused by stimulating ipsilateral primary motor cortex.

Sponsors and collaborators

Lead sponsor

The Hong Kong Polytechnic University

Other

Collaborators

  • Queen Mary Hospital, Hong Kong

Registry information

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Dec 8, 2020
Registry last updated
Feb 2, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.